Maria Hryniewiecka, MD

Department of Hematology and Bone Marrow Transplantation, Polish Red Cross Maritime Hospital, Poland

Poster(s):

• 1406 - Venetoclax and obinutuzumab in first-line treatment of unfit patients with CLL – real-life data analysis of the Polish Adult Leukemia Group